 |
|
SV Life Sciences is a leading international
life sciences venture capital firm. SVLS affiliated funds have been
investing in life sciences companies since the early 1980s and the
firm closed its first dedicated life sciences fund in 1994. The SVLS
team manages six venture capital funds and a publicly traded investment
trust with approximately $2 billion of capital under management. The
firm employs a diversified strategy within life sciences in order to
selectively capitalize on an expanding opportunity in biotech, medical
devices and health-care services. SVLS has offices in Boston,
London and San Francisco.
SVLS was started in London as Schroder Ventures Life Sciences in 1993 as part of the Schroder Ventures Group. SVLS became independent of the Schroder Ventures Group in 2001, and in January 2005 changed its name to SV Life Sciences to reflect independent ownership. SV Life Sciences NewsIn the UK, SV Life Sciences Advisers LLP (registered in England OC 308830, VAT 852 5150 39) and SV Life Sciences Managers LLP (registered in England number OC 308829, VAT 852 4012 56) are authorised and regulated by the Financial Services Authority ('FSA'). They are entered into the FSA's register and their registration numbers are Advisers LLP - 409123 and Managers LLP 409119. The registered office of both entities is 71 Kingsway, London, WC2B 6ST. |
|